About the Lung Transplant Program

Organ transplantation offers great promise for children with end-stage lung disease. If your child is referred to the Pediatric Lung Transplant Program at CHOP, we will evaluate him and meet with your family before your child is placed on the transplant list. Our goal is first to investigate other treatment options that could improve your child's health and quality of life. We explore medical therapies and other types of surgeries that may eliminate the need for transplantation.

We consider lung transplantation if a child has end-stage pulmonary (lung) disease, his or her life expectancy is limited and no other treatment options are available. A child may need a transplant if he or she has certain conditions, including:

  • Cystic fibrosis
  • Primary pulmonary hypertension
  • Interstitial lung disease
  • Bronchiolitis obliterans
  • Surfactant protein deficiencies
  • Congenital malformation with inadequate lung development
  • Pulmonary veno-occlusive disease
  • Heart disease or heart defects (may require a heart-lung transplant)

Whether your child would benefit from lung transplantation is a complex issue that must be carefully and individually evaluated. If you are considering a lung or heart/lung transplant evaluation, please request an evaluation with the Lung Transplant Program at The Children's Hospital of Philadelphia as early as possible.

Our lung transplant team

Under the leadership of Thomas Spray, MD, Surgical Director of Thoracic Organ Transplant, and Samuel Goldfarb, MD, Medical Director, Lung Transplantation, our program is known both for its excellence and for its comprehensive approach to care. We have performed more than 70 lung transplants and our outcomes are among the best in the world.

Research

The Children’s Hospital of Philadelphia Lung Transplant Program is dedicated to researching advanced lung diseases and providing the best treatment and care for pediatric lung transplant patients. Our program has earned a reputation of clinical excellence and advanced research, and funding continues to grow.